Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Heparinase gene covered by U.S., European patents

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

Reteplase and alteplase exhibit different profiles of fibrin binding at high doses

Sep. 10, 1997

U.S. patent for antithrombotic agents issued to Burnham Institute

Sep. 10, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

RPR discloses new factor Xa inhibitors

Sep. 10, 1997

Promising phase II results for Genzyme Transgenics' rhATIII

Sep. 9, 1997

Novastan granted priority review status by FDA

Sep. 9, 1997

T-686 inhibits thrombus formation without hemostatic impairment

Sep. 5, 1997

RPR scientists try a new approach to gpIIb/IIIa antagonists

Sep. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...